External Counterpulsation Therapy (EECP and ECP Therapy) has documented great benefit for many cardiac patients in several credible, peer reviewed journals such as the New England Journal of Medicine and the Journal American College of Cardiology. However, in order to be eligible for reimbursement from Medciare & private insurance, you must adhere to the standard guidelines put forth by the Centers for Medicare & Medicaid.
Candidates for ECP Therapy and EECP Therapy must fit the following Criteria:
- Documented minimal Coronary Artery Disease (Objective Assessment “B” means evidence of minimum cardiovascular disease) by way of Angiography, Stress test, Nuclear scan, Cardiac Ultrasound, EKG, Holter etc.
- Symptoms with Physical Exertion – Patients that are comfortable at rest, but less than ordinary physical activity cause:
- Chest Pain
- Shortness Of Breath
- Symptomns of Ischemic Heart Failure
- Patients are In-operable:
- Patients with excessive risk or co-morbid condition that creates unnecessary risk for invase procedure.
- Patients who refuse or unwilling to take risk of another invasive proceedure due to age
- Inadequate Relief from Medication or Complications with excessive medications.
- ECP Therapy is proven to reduce or often eliminate need for medications (Nitrates, Ranexa)
Patient Groups to Consider:
- Post Invasive Patients are a great place to find ideal candidates for External Counterpulsation Therapy. These are patients that have had a Bipass Surgery (CABG) or Percutaneous Coronary Intervention (PCI) within the last 5 years or more. Statistics show that these patients will be symptomatic as soon as 1 year and the idea of a safe, non-invasive treatment option will be an attractive options for this group. Most cardiology practices average 400-600 active patients in this group (based on average practice size of 2500 active patients) with 75-95 of that number could qualify for ECP therapy.
- Diabetic Patients with underlying ischemic heart disease that suffer from neuropathy often have symptoms of Shortness of Breath on physical exertion. These patients a could often benefit greatly from ECP therapy due to the fact that many of these patients live an inactive and unhealthly lifestyle that can benefit from the improvement in peripherial & arterial function brought from ECP therapy. Further, many of these patients are NOT good candidates for surgery as many have excessive risk and post operation complications.
- In-Active or Sedintary Lifestyle patients are also great candidates for External Counterpulsation Therapy. These are the patients that avoid any activity that brings them any discomfort. Many experts say that External Counterpulsation therapy provides as much as 6 times the amount of exercise benefit per hour of treatment than any other form of tolerated physical exercise. Many of these patients are obese or elderly with many health compications that pose as a significant risk factor for other traditional invasive procedures.
- Small vessel or diffuse disease resulting in symptoms
- Incomplete revascularization or in-operable legions / vessels
- Congestive Heart Failure patients with various symptoms with documented underlying Ischemia / CAD
- CAD patients that live sedentary lifestyles due to CAD
- Patients looking to restore exercise tolerance / functional capacity
- Cardiac Syndrome X (undetectable symptoms of chest pain)
- Patient that take excessive medication (Nitro, Ranexa) or do not get ample relief.
- Patients looking to restore a more active quality of life.
Although the patient benefits of External Counterpulsation Therapy have proven to last for more than 5 years, it is not uncommon for Medicare to pay for reimbursement for repeat treatment session (35 days) once each year. Be sure to check with your “Local Coverage Determination” for the details on frequency of treatment as well as the exact details on therapy eligibility.
For National Coverage information, you can visit Medicare Guidelines for the current by clicking here for the “National Coverage Determination” for External Counterpulsation Therapy.
Based on the revised guidelines described above, you can now see why physicians that may have previously “ruled out” External Counterpulsation Therapy (due to strict guidelines) are now making the service available for their patients in 2012. Although the subset of patients that qualify and benefits is not for every patient, it is now easier than ever to select your most prominent 20-40 patients over the course of one full year.